Introgen Therapeutics Inc. is a biotechnology company based in Austin, Texas, specializing in the development of innovative cancer therapies. The organization focuses on gene therapy and immunotherapy, aiming to harness the body's immune system to combat various forms of cancer. With a commitment to advancing treatment options, Introgen engages in research that explores novel approaches to enhance the efficacy and safety of cancer treatments, contributing to the evolving landscape of oncology therapeutics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#296 in Austin, TX

#1,879 in Texas

#29,839 in US

#55,986 in the World

Austin, TX, United States of America

Introgen Therapeutics Inc.

Forward Citations = 331

12 inventors:

Shuyuan Zhang (8 out of 12 patents)

Zheng Wu (7 out of 10 patents)

Capucine Thwin (5 out of 6 patents)

4. Toohyon Cho (5 out of 6 patents)

5. Deborah R Wilson (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Introgen Therapeutics Inc.. Retrieved from https://idiyas.com/company/introgen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]